- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ibrutinib ofatumumab
Total 523 results
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicAustralia, United States, New Zealand
-
Esanex Inc.TerminatedCancerUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
University of Southern CaliforniaNovartis PharmaceuticalsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsActive, not recruiting
-
Grupo Espanol de trasplantes hematopoyeticos y...GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedLeukaemiaBelgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineWithdrawnLymphoma, FollicularUnited States
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicSpain, United States, Belgium, India, United Kingdom, Netherlands, Czechia, Germany, Greece, Italy, Russian Federation, Sweden, Canada, Ireland, Poland, France, Brazil
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineWithdrawnLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
-
Novartis PharmaceuticalsNot yet recruiting
-
University of NebraskaGlaxoSmithKline; Celgene CorporationCompletedNon-Hodgkin's LymphomaUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
GlaxoSmithKlineGenmabCompletedLeukaemia, Lymphocytic, ChronicSweden
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidItaly, Argentina, Germany, Peru, Korea, Republic of, Denmark, Spain, Sweden, France, Netherlands, Norway, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
University Hospital, CaenNot yet recruitingAtrial Fibrillation | Hematological MalignancyFrance
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Tianjin Medical University General HospitalRecruitingMultiple Sclerosis | Neuromyelitis Optica Spectrum Disorder | Demyelinating Diseases of the Central Nervous SystemChina
-
Georgetown UniversityGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Poland, Austria, Belgium, Czechia, Germany, Australia, Switzerland, Lebanon, Argentina, Canada, Slovenia, Bulgaria, Latvia, Russian Federation, Spain, Italy, Turkey, Slovakia, Portugal, Greece, Saudi Arabia, Hungary, No... and more
-
University of OxfordGlaxoSmithKline; Cancer Research UK; Oxford University Hospitals NHS Trust; NCRI...CompletedRichter's SyndromeUnited Kingdom
-
Novartis PharmaceuticalsTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Peter MacCallum Cancer Centre, AustraliaNovartisActive, not recruitingMantle Cell Lymphoma RecurrentAustralia
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
-
Merck Sharp & Dohme LLCCompletedChronic Lymphocytic Leukemia (CLL)
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Novartis PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedB-cell Lymphoma | Marginal Zone LymphomaUnited States, Belgium, France, Germany, United Kingdom
-
Janssen Research & Development, LLCCompleted
-
Incyte CorporationCompleted
-
German CLL Study GroupJanssen-Cilag Ltd.CompletedChronic Lymphocytic LeukemiaGermany
-
University of Michigan Rogel Cancer CenterWithdrawnMantle Cell LymphomaUnited States